Anticorps Monoclonal anti-ENO3
ENO3 Monoclonal Antibody for WB, IF/ICC, Indirect ELISA
Hôte / Isotype
Mouse / IgG2b
Réactivité testée
Humain, porc, rat, souris
Applications
WB, IF/ICC, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
2C12G3
N° de cat : 68147-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
68147-1-PBS cible ENO3 dans les applications de WB, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain, porc, rat, souris
| Réactivité | Humain, porc, rat, souris |
| Hôte / Isotype | Mouse / IgG2b |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | ENO3 Protéine recombinante Ag9642 |
| Nom complet | enolase 3 (beta, muscle) |
| Masse moléculaire calculée | 434 aa, 47 kDa |
| Poids moléculaire observé | 42-47 kDa |
| Numéro d’acquisition GenBank | BC017249 |
| Symbole du gène | ENO3 |
| Identification du gène (NCBI) | 2027 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
Enolase 3 (ENO3) encodes the β-subunit of enolase, which is distributed in various tissues, including liver, lung, skeletal, and heart. ENO3 plays an important role in both glycogen and cholesterol metabolism. It has been demonstrated that ENO3 deficiency may lead to metabolic myopathies, and ENO3 speeds up hepatic cholesterol ester cumulation induced via the mediation of cholesteryl ester generation.Apart from these, ENO3 has also been involved in various tumors, though the results are contradictory. For example, ENO3 is up-regulated in STK11 mutant pulmonary carcinoma and colorectal carcinoma, while down-regulated in pancreatic cancer and hepatocellular carcinomas. ENO3 has 3 isoforms with the molecular mass of 42-47 kDa. (PMID: 33987359, 35004693)



